Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
Institute of Hygiene, University Hospital Münster, Münster, Germany.
Support Care Cancer. 2022 Sep;30(9):7231-7239. doi: 10.1007/s00520-022-07140-0. Epub 2022 May 19.
Children and adolescents undergoing treatment for cancer or allogeneic hematopoietic cell transplantation are at increased risk for methicillin-resistant Staphylococcus aureus (MRSA). We therefore examined the occurrence and outcome of MRSA colonization and infection in patients of a large European pediatric cancer center.
In a prospective observational cohort study conducted between 2007 and 2018, nasopharyngeal swabs for culture of MRSA were obtained from all admitted patients. The primary endpoint of the study was the colonization rate over time. Secondary endpoints included genetic relatedness of isolates, time burden of isolation measures, and results of decolonization efforts.
During the study period, MRSA screening identified 34 colonized patients (median age: 10 years; range: 0-21) without trends over time. MRSA colonization was associated with the presence of classical risk factors. There was no molecular evidence of patient-to-patient transmission. A standard MRSA eradication regimen led to a lasting eradication of the organism in 26 of 34 patients. MRSA infection occurred in two patients with no associated fatalities.
Prospective monitoring revealed low rates of MRSA colonization and infection at our center. These low rates and the absence of patient-to-patient transmission support the effectiveness of the management bundle of MRSA identification, isolation, and decolonization.
接受癌症或同种异体造血细胞移植治疗的儿童和青少年感染耐甲氧西林金黄色葡萄球菌(MRSA)的风险增加。因此,我们检查了一家大型欧洲儿科癌症中心患者中 MRSA 定植和感染的发生和结果。
在 2007 年至 2018 年期间进行的一项前瞻性观察队列研究中,从所有入院患者中采集鼻咽拭子进行 MRSA 培养。该研究的主要终点是随时间推移的定植率。次要终点包括分离株的遗传相关性、隔离措施的时间负担以及去定植效果的结果。
在研究期间,MRSA 筛查确定了 34 例定植患者(中位年龄:10 岁;范围:0-21 岁),无随时间推移的趋势。MRSA 定植与存在经典危险因素有关。没有患者间传播的分子证据。标准的 MRSA 根除方案导致 34 例患者中的 26 例持续根除该病原体。两名患者发生 MRSA 感染,但无相关死亡。
前瞻性监测显示,我们中心的 MRSA 定植和感染率较低。这些低比率和不存在患者间传播支持了 MRSA 识别、隔离和去定植管理方案的有效性。